DI AGOSTINO, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.530
AS - Asia 1.223
EU - Europa 480
SA - Sud America 444
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 30
OC - Oceania 1
Totale 3.875
Nazione #
US - Stati Uniti d'America 1.471
SG - Singapore 509
BR - Brasile 346
CN - Cina 280
IT - Italia 253
VN - Vietnam 180
IN - India 95
HK - Hong Kong 60
SE - Svezia 45
DE - Germania 43
AR - Argentina 39
GB - Regno Unito 38
NL - Olanda 28
EC - Ecuador 22
ID - Indonesia 22
CA - Canada 20
BD - Bangladesh 18
MX - Messico 17
EU - Europa 15
FR - Francia 14
RU - Federazione Russa 13
CO - Colombia 9
CZ - Repubblica Ceca 9
FI - Finlandia 9
IQ - Iraq 9
PY - Paraguay 9
JP - Giappone 8
MA - Marocco 8
UA - Ucraina 8
TR - Turchia 7
PL - Polonia 6
ZA - Sudafrica 6
CL - Cile 5
KE - Kenya 5
KR - Corea 5
AT - Austria 4
CR - Costa Rica 4
GT - Guatemala 4
NI - Nicaragua 4
PE - Perù 4
UY - Uruguay 4
UZ - Uzbekistan 4
VE - Venezuela 4
EG - Egitto 3
IL - Israele 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
BO - Bolivia 2
DZ - Algeria 2
HN - Honduras 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AW - Aruba 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
Totale 3.724
Città #
San Jose 319
Singapore 161
Chandler 121
Santa Clara 113
Ashburn 103
Council Bluffs 82
Bengaluru 77
Hefei 75
Ho Chi Minh City 73
Beijing 65
Hong Kong 58
Milan 58
Princeton 58
Lawrence 57
Dallas 48
Rome 38
Chicago 37
Wilmington 36
Hanoi 34
São Paulo 32
Munich 27
Des Moines 23
London 20
Boardman 19
Phoenix 18
New York 14
Los Angeles 13
Rio de Janeiro 11
Shanghai 11
Haiphong 10
Da Nang 9
Hanover 8
Olomouc 8
Rende 8
The Dalles 8
Toronto 8
West Jordan 8
Amsterdam 7
Florence 7
Manaus 7
Palermo 7
Quito 7
Biên Hòa 6
Buffalo 6
Campinas 6
Catania 6
Curitiba 6
Helsinki 6
Mexico City 6
Montreal 6
Norwalk 6
San Nicola Manfredi 6
Tokyo 6
Belo Horizonte 5
Brasília 5
Brooklyn 5
Fortaleza 5
Naples 5
Ninh Bình 5
Philadelphia 5
Porto Alegre 5
San Francisco 5
Stockholm 5
Thái Bình 5
Warsaw 5
Ankara 4
Asunción 4
Bauru 4
Bologna 4
Boston 4
Buenos Aires 4
Casablanca 4
Guarulhos 4
Guayaquil 4
Gwangjin-gu 4
Managua 4
Montevideo 4
Nairobi 4
Osasco 4
Pune 4
Salvador 4
Seattle 4
Sesto Fiorentino 4
Thái Nguyên 4
Vallefiorita 4
Abreu e Lima 3
Atlanta 3
Aversa 3
Baghdad 3
Cotronei 3
Criciúma 3
Duque de Caxias 3
Florianópolis 3
Indaiatuba 3
Jakarta 3
Johannesburg 3
La Plata 3
Lecce 3
Lima 3
Lomas de Zamora 3
Totale 2.154
Nome #
Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment 120
Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids: Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery 98
Harnessing Azelaic Acid for Acute Myeloid Leukemia Treatment: A Novel Approach to Overcoming Chemoresistance and Improving Outcomes 69
Detection of the Lassa Virus in a Group of Odontogenic Bone Tumor Tissues 69
MicroRNAs in head and neck squamous cell carcinoma: A possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies 66
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins 65
Prolin-rich tyrosine kinase 2 (PYK2) expression and localization in mouse testis 65
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer 64
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells 63
Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression 61
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence 61
New molecular mechanisms and clinical impact of circrnas in human cancer 61
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 59
Genomic instability: The pivotal role of mutant p53 in human cancers 59
Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development 58
Molecular insights unlocking therapeutic potential for multiple myeloma and bone disease management 57
Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer 57
Isolation and characterization of three polyamine oxidase genes from Zea mays 57
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies 57
Arenavirus as a potential etiological agent of odontogenic tumours in humans 56
Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy 56
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation 56
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells 56
The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1 55
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain 55
The Effects of Caloric Restriction on Inflammatory Targets in the Prostates of Aged Rats 54
17-β-estradiol elicits genomic and non-genomic responses in mouse male germ cells 54
HMGA1 and HMGA2 protein expression in mouse spermatogenesis 54
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 54
The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein 53
Analysis of the gene expression profile of mouse male meiotic germ cells 53
Proteomic profiling identifies a stromal TGF-β1/podoplanin axis as a driver of colorectal cancer progression 52
Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion 52
Prostate Cancer: Emerging Modifiable Risk Factors and Therapeutic Strategies in the Management of Advanced Cancer 51
The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs 51
Long non-coding MIR205HG depletes Hsa-miR-590-3p leading to unrestrained proliferation in head and neck squamous cell carcinoma 51
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 51
Calorie-restriction treatment mitigates the aging in rat liver model 51
MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer 49
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function 49
Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation 49
PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop 48
A Combined atomic force microscopy imaging and docking study to investigate the complex between p53 DNA binding domain and azurin 47
Oncogenic intra-p53 family member interactions in human cancers 46
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 46
Maize polyamine oxidase: Primary structure from protein and cDNA sequencing 45
Interaction of mutant p53 with p73: A Surface Plasmon Resonance and Atomic Force Spectroscopy study 45
The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts 45
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 45
MiR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer 45
Promyelocytic leukemia protein is required for gain of function by mutant p53 45
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma 45
Gender, mutant p53 and PML: A growing "affaire" in tumor suppression and oncogenesis 44
Signaling through Extracellular Signal-regulated Kinase Is Required for Spermatogonial Proliferative Response to Stem Cell Factor 44
Phosphorylation of High-Mobility Group Protein A2 by Nek2 Kinase during the First Meiotic Division in Mouse Spermatocytes 44
Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer 42
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease 42
Mutant p53: An oncogenic transcription factor 42
Mutant p53 proteins: Between loss and gain of function 41
Meiotic progression of isolated mouse spermatocytes under simulated microgravity 41
3D Spheroid Culture of Human Nasal Polyp Cells: A Functional Organoid-Like Model for Assessing Epithelial Restoration in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) 40
New therapeutic strategies to treat human cancers expressing mutant p53 proteins 40
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 40
Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments 39
Loss of two-pore channel 2 (TPC2) expression increases the metastatic traits of melanoma cells by a mechanism involving the hippo signalling pathway and store-operated calcium entry 37
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer 36
PML surfs into HIPPO tumor suppressor pathway 36
Novel Insights into the Role of the Antioxidants in Prostate Pathology 35
The MAPK pathway triggers activation of Nek2 during chromosome condensation in mouse spermatocytes 35
Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease 35
The impact of mutant p53 in the non-coding RNA world 33
The miR-205-5p/BRCA1/RAD17 axis promotes genomic instability in head and neck squamous cell carcinomas 32
Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth 28
Targeting mutant p53 in cancer: The latest insights 26
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis 26
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine 25
Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop 25
Urogenital Cancers: New Molecular and Translational Aspects on Carcinogenesis and Treatments 19
Caloric restriction attenuates oxidative and inflammatory markers of aging, while compromising germinative epithelium homeostasis in the rat aged testis 18
Totale 3.875
Categoria #
all - tutte 35.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 0 0 0 34 10 12 3 31 14 19 37 14
2022/2023363 122 43 15 33 13 21 7 13 30 33 22 11
2023/2024196 38 14 7 12 12 32 7 10 8 11 18 27
2024/2025706 108 10 11 23 69 84 17 32 127 25 57 143
2025/20261.960 81 179 247 488 180 59 166 83 268 103 74 32
2026/2027379 27 113 185 54 0 0 0 0 0 0 0 0
Totale 3.875